Oral fumarate for relapsing-remitting multiple sclerosis
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Oral fumarate for relapsing-remitting multiple sclerosis. / Sorensen, P.S.; Sellebjerg, F.
In: Lancet, Vol. 372, No. 9648, 2008, p. 1447-1448.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Sorensen, PS & Sellebjerg, F 2008, 'Oral fumarate for relapsing-remitting multiple sclerosis', Lancet, vol. 372, no. 9648, pp. 1447-1448.
APA
Sorensen, P. S., & Sellebjerg, F. (2008). Oral fumarate for relapsing-remitting multiple sclerosis. Lancet, 372(9648), 1447-1448.
Vancouver
Sorensen PS, Sellebjerg F. Oral fumarate for relapsing-remitting multiple sclerosis. Lancet. 2008;372(9648):1447-1448.
Author
Bibtex
@article{76b448509c6511debc73000ea68e967b,
title = "Oral fumarate for relapsing-remitting multiple sclerosis",
abstract = "Udgivelsesdato: 2008/10/25",
author = "P.S. Sorensen and F. Sellebjerg",
note = "Cochrane: OK. Letter fra Lancet accepteres.",
year = "2008",
language = "English",
volume = "372",
pages = "1447--1448",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "9648",
}
RIS
TY - JOUR
T1 - Oral fumarate for relapsing-remitting multiple sclerosis
AU - Sorensen, P.S.
AU - Sellebjerg, F.
N1 - Cochrane: OK. Letter fra Lancet accepteres.
PY - 2008
Y1 - 2008
N2 - Udgivelsesdato: 2008/10/25
AB - Udgivelsesdato: 2008/10/25
M3 - Journal article
VL - 372
SP - 1447
EP - 1448
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 9648
ER -
ID: 14276990